US FDA approves Bristol Myers' blood cancer treatment

The U.S. FDA on ​Thursday approved Bristol Myers Squibb's ‌combination treatment for patients with a rare form of blood cancer whose illness had ​relapsed or not responded ​to other treatments, the he...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。